722 participants
Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly Subjects
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2015-10-12
- Start Date:
- 2009-09-30
- Completion:
- 2009-12-31
Conditions
- Pandemic H5N1 Influenza
Interventions
- BIOLOGICAL
No Results Yet